Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 5076-5085, July 1, 2008. doi: 10.1158/0008-5472.CAN-08-0634
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Morishita, D.
Right arrow Articles by Fujita, N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morishita, D.
Right arrow Articles by Fujita, N.

Molecular Biology, Pathobiology, and Genetics

Pim Kinases Promote Cell Cycle Progression by Phosphorylating and Down-regulating p27Kip1 at the Transcriptional and Posttranscriptional Levels

Daisuke Morishita1,2, Ryohei Katayama1, Kazuhisa Sekimizu2, Takashi Tsuruo1 and Naoya Fujita1

1 Cancer Chemotherapy Center, Japanese Foundation for Cancer Research and 2 Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan

Requests for reprints: Naoya Fujita, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan. Phone: 81-33570-0468; Fax: 81-3-3570-0484; E-mail: naoya.fujita{at}jfcr.or.jp.

Key Words: Pim kinase • p27Kip1 • FoxO transcription factor • cell cycle • cancer chemotherapy

The serine/threonine kinase Pim is known to promote cell cycle progression and to inhibit apoptosis leading to tumorigenesis. However, the precise mechanisms remain unclear. We show, herein, that all the Pim family members (Pim1, Pim2, and Pim3) bind to and directly phosphorylate the cyclin-dependent kinase inhibitor p27Kip1 at threonine-157 and threonine-198 residues in cells and in vitro. The Pim-mediated phosphorylation induced p27Kip1 binding to 14-3-3 protein, resulting in its nuclear export and proteasome-dependent degradation. Ectopic expression of Pim kinases overcome the G1 arrest mediated by wild-type p27Kip1 but not by phosphorylation-resistant T157A-p27Kip1 or T198A-p27Kip1. In addition to the posttranslational regulations, p27Kip1 promoter assay revealed that Pim kinases also had the ability to suppress p27Kip1 transcription. Pim-mediated phosphorylation and inactivation of forkhead transcription factors, FoxO1a and FoxO3a, was involved in the transcriptional repression of the p27Kip1 gene. In contrast, inhibition of Pim signaling by expressing the dominant-negative form of Pim1 increased nuclear p27Kip1 level and attenuated cell proliferation. Because the CDK inhibitor p27Kip1 plays a crucial role in tumor suppression by inhibiting abnormal cell cycle progression, Pim kinases promote cell cycle progression and tumorigenesis by down-regulating p27Kip1 expression at both transcriptional and posttranslational levels. [Cancer Res 2008;68(13):5076–85]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.